Testing Interventions for Borderline Personality Disorder.

Recruiting Phase 2 Interventional Study
Borderline Personality Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
304 (estimated)
Sponsor
York University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Borderline personality disorder (BPD) is a life-threatening, costly public health crisis affecting \~1-3% of North Americans, with 10% dying by suicide and annual healthcare costs of \~$63k (Canadian Dollars)/patient. Further, people with BPD's intimate relationships are highly disrupted, and their partners report elevated mental health problems but little access to treatment. Existing BPD treatme…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
INCLUSION CRITERIA 1. Participant with borderline personality disorder (BPD) meets full diagnostic criteria for BPD (i.e., five or more BPD diagnostic criteria per the Diagnostic and Statistical Manual of Mental Disorders-5-TR) 2. Both members are at least 19-years-old 3. Both members consent to st…
Contacts

Skye Fitzpatrick, PhD

461-736-2100

skyefitz@yorku.ca

CONTACT